Status:
UNKNOWN
Detoxification and Treatment of Subjects With Medication Overuse Headache
Lead Sponsor:
The New England Center for Headache, P.C.
Collaborating Sponsors:
Ortho-McNeil Neurologics, Inc.
Conditions:
Analgesic Rebound Headache
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to assess the benefits of almotriptan used as a transitional therapy and topiramate in subjects with medication overuse headaches (MOH.
Eligibility Criteria
Inclusion
- Medication overuse headaches 18 years of age and older Must have a diagnosis of probable medication overuse headache Must have greater than fifteen headache days per month Must be in generally good health Female subjects must be postmenopausal or practicing an acceptable method of birth control
Exclusion
- Not overusing six or more tablets per day of compounds containing barbituates opioids No overuse of triptans Previous failure or side effects with topiramate or almotriptan Cannot be pregnant or lactating
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
End Date :
February 1 2007
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00432549
Start Date
January 1 2007
End Date
February 1 2007
Last Update
February 8 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The New England Center for Headache, P.C.
Stamford, Connecticut, United States, 06902